scispace - formally typeset
Journal ArticleDOI

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

TLDR
In patients with laryngeal cancer, radiotherapy with concurrent administration of cisplatin is superior to induction chemotherapy followed by radiotherapy or radiotherapy alone for larynGEal preservation and locoregional control.
Abstract
Background Induction chemotherapy with cisplatin plus fluorouracil followed by radiotherapy is the standard alternative to total laryngectomy for patients with locally advanced laryngeal cancer. The value of adding chemotherapy to radiotherapy and the optimal timing of chemotherapy are unknown. Methods We randomly assigned patients with locally advanced cancer of the larynx to one of three treatments: induction cisplatin plus fluorouracil followed by radiotherapy, radiotherapy with concurrent administration of cisplatin, or radiotherapy alone. The primary end point was preservation of the larynx. Results A total of 547 patients were randomly assigned to one of the three study groups. The median follow-up period was 3.8 years. At two years, the proportion of patients who had an intact larynx after radiotherapy with concurrent cisplatin (88 percent) differed significantly from the proportions in the groups given induction chemotherapy followed by radiotherapy (75 percent, P=0.005) or radiotherapy alone (70 ...

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base.

TL;DR: Outcomes data are presented using simultaneous modulated accelerated radiation therapy (SMART) combined with platinum‐based chemotherapy in treatment of locally advanced SCC of the BOT.
Journal ArticleDOI

Concurrent Chemotherapy and Re-irradiation for Locoregionally Recurrent Head and Neck Cancer

TL;DR: The basis for current chemoradiotherapy (CRT) regimens used in previously radiated patients, focusing on outcome and toxicity are reviewed, and controversies, such as the utility of chemotherapy and RRT following surgical salvage, are addressed.
Journal ArticleDOI

Primary and Salvage Total Laryngectomy

TL;DR: The role of total laryngectomy is not extinct and still plays an important role in primary therapy for advanced stagelaryngeal cancers and as salvage therapy for failures of organ preservation strategies.
Journal ArticleDOI

Primary radiotherapy compared with primary surgery in cervical esophageal cancer.

TL;DR: Given the similarities in rates of local failure-free survival, regional FFS, distant F FS, and overall survival between the primary RT and primary surgery CEC treatment groups, it is recommended primary RT for larynx preservation, with surgery offered subsequently for patients who do not respond to RT.
Journal ArticleDOI

Effectiveness of chemoradiation for head and neck cancer in an older patient population.

TL;DR: Although the addition of chemotherapy to radiation has proven efficacious in many randomized controlled trials, it may be less effective in an older patient population treated outside of a controlled trial setting.
References
More filters
Book ChapterDOI

Nonparametric Estimation from Incomplete Observations

TL;DR: In this article, the product-limit (PL) estimator was proposed to estimate the proportion of items in the population whose lifetimes would exceed t (in the absence of such losses), without making any assumption about the form of the function P(t).
Journal ArticleDOI

A Multiple Comparison Procedure for Comparing Several Treatments with a Control

TL;DR: In this article, a multiple comparison procedure for comparing several treatments with a control is presented, which is based on the Multiple Comparison Procedure for Comparing Several Treatments with a Control (MCPC).
Journal ArticleDOI

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

Robert Gray
- 01 Jan 1988 - 
TL;DR: In this paper, a class of tests developed for comparing the cumulative incidence of a particular type of failure among different groups is presented. The tests are based on comparing weighted averages of the hazards of the subdistribution for the failure type of interest.
Journal ArticleDOI

Cancer statistics, 2003.

TL;DR: The American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year, and compiles the most recent data on cancer incidence, mortality, and survival by using incidence data from the National Cancer Institute (NCI) and mortality data from National Center for Health Statistics (NCHS).
Related Papers (5)